We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-0.27%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.92B
AUM Growth
+$75.1M
Cap. Flow
+$135M
Cap. Flow %
3.46%
Top 10 Hldgs %
32.39%
Holding
6,700
New
1,026
Increased
2,252
Reduced
2,490
Closed
691

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$342M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$83.1M
3
VOO icon
Vanguard S&P 500 ETF
VOO
+$43.8M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$40.2M
5
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$26.6M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$19.9M
2
SOXX icon
iShares Semiconductor ETF
SOXX
+$19M
3
EFA icon
iShares MSCI EAFE ETF
EFA
+$18.2M
4
CRM icon
Salesforce
CRM
+$16.1M
5
TSLA icon
Tesla
TSLA
+$14.7M

Sector Composition

Rank Sector Weight
1 Technology 18.5%
2 Consumer Discretionary 8.04%
3 Healthcare 7.14%
4 Communication Services 6.4%
5 Financials 6.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SMC
6251
Summit Midstream
SMC
$419M
$0 ﹤0.01%
+11
New +$389
OMCC
6252
DELISTED
Old Market Capital Corp
OMCC
– –
-833
Closed -$9K
HURA
6253
TuHURA Biosciences
HURA
$136M
– –
-2
Closed -$7K
AIFU
6254
AIFU Inc
AIFU
$221M
– –
-1
Closed -$5.57K
IRD
6255
Opus Genetics
IRD
$302M
– –
-3,312
Closed -$17K
GRCE
6256
Grace Therapeutics
GRCE
$34.7M
$0 ﹤0.01%
+32
New +$630
ENFY
6257
DELISTED
Enlightify Inc
ENFY
– –
-177
Closed -$2K
MTVA
6258
MetaVia Inc
MTVA
$7.69M
– –
-2
Closed -$18.9K
PVLA
6259
Palvella Therapeutics
PVLA
$2.27B
– –
-144
Closed -$50.1K
RNTX
6260
Rein Therapeutics
RNTX
$69.9M
– –
-136
Closed -$3K
BLNE
6261
Beeline Holdings
BLNE
$33.2M
– –
-1
Closed –
EVBN
6262
DELISTED
Evans Bancorp Inc
EVBN
– –
-43
Closed -$2K
AMPS
6263
DELISTED
Altus Power
AMPS
– –
-12
Closed –
AE
6264
DELISTED
Adams Resources & Energy Inc
AE
– –
-78
Closed -$2K
IBTE
6265
DELISTED
iShares iBonds Dec 2024 Term Treasury ETF
IBTE
– –
-2
Closed –
BROGW
6266
DELISTED
Brooge Holdings Limited Warrant expiring 12/20/2024
BROGW
$0 ﹤0.01%
7
– –
FRES
6267
DELISTED
Fresh2 Group Limited American Depositary Shares
FRES
– –
-6
Closed -$5K
WHLM
6268
DELISTED
Wilhelmina International, Inc
WHLM
– –
-1,891
Closed -$9K
LUMO
6269
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$0 ﹤0.01%
1
-122
-99% -$1.15K
MOND
6270
DELISTED
Mondee Holdings, Inc. Class A Common Stock
MOND
$0 ﹤0.01%
+29
New +$282
PMD
6271
DELISTED
Psychemedics Corporation
PMD
– –
-390
Closed -$3K
TFFP
6272
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
– –
-211
Closed -$50K
JWSM
6273
DELISTED
Jaws Mustang Acquisition Corp.
JWSM
– –
-689
Closed -$7K
ORAN
6274
DELISTED
Orange
ORAN
– –
-11,001
Closed -$126K
GHSI
6275
DELISTED
Guardion Health Sciences, Inc. Common Stock
GHSI
$0 ﹤0.01%
2
+1
+100% +$67
249 250
251
252 253

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2021 Portfolio in Review

As of Q3 2021, Tower Research Capital (TRC) held 6,700 positions worth $3.92B, up 2% from $3.84B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) deployed $135M of net new capital in Q3 2021, opening 1,026 new positions and adding to 2,252 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 107,857 shares worth $42.5M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was UnitedHealth, an estimated $19.9M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2021 buy was Vanguard S&P 500 ETF: 107,857 shares worth $42.5M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $342M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2021 reduction was UnitedHealth, cutting an estimated $19.9M.
  • Tower Research Capital (TRC) fully exited iShares Semiconductor ETF in Q3 2021, selling an estimated $19M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $3.92B portfolio in Q3 2021.
  • Tower Research Capital (TRC) opened 1,026 new positions and closed 691 in Q3 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 2% quarter-over-quarter to $3.92B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2021, filed 15 Nov 2021.